Optimising management of hypertension: use of calcium channel blockers (CCBs) vs. ARBs and use of CCB/ARB combination therapy. Part 2

Optimising management of hypertension: use of calcium channel blockers (CCBs) vs. ARBs and use of CCB/ARB combination therapy. In this second part, Professor Ruilope discusses the clinical evidence for combining CCB and ARB therapies and whether this leads to protection of the cardiovascular and renal systems simultaneously.
Login/ Register Maximise Minimise